Troy Edward Wilson

Troy Edward Wilson discloses dealings in 3 companies, chiefly Kura Oncology, Inc., Puma Biotechnology, Inc. and Avidity Biosciences, Inc. Between 10 June 2021 and 14 September 2026, the trades on record add up to 28 filings.

In open-market terms, that means 4 purchases worth €2.6M on one side and 8 sales worth €1.8M on the other. Taken together, the purchases exceed the sales by €737k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants and 4 option exercises. In 2026 alone, the filings show 2 purchases and 1 sale.

The median purchase comes to €654k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 16 September 2026, the filings show an open-market sale worth €39k in Puma Biotechnology, Inc. The clock since the last published purchase (24 August 2026) now reads 55 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.